Gold is 2025’s best performer. UBS sees more upside
PHILADELPHIA - FMC Corporation (NYSE:FMC), a profitable agricultural technology company with a notable 5.9% dividend yield and 20-year track record of consistent dividend payments, announced Thursday it has secured registration in Great Britain for its Fundatis herbicide for use in winter wheat and winter barley crops. According to InvestingPro analysis, the company appears undervalued at current levels, despite recent market challenges that saw its stock decline nearly 10% in the past week.
The herbicide combines FMC’s Isoflex active ingredient with beflubutamid, providing farmers with a new tool for managing herbicide-resistant weeds. According to the company, Fundatis is classified as a Group 13 herbicide by the Herbicide Resistance Action Committee.
The product targets key annual grass weeds including Blackgrass and Italian Ryegrass, along with broadleaf weeds such as Groundsel and Speedwell. It will be available to British farmers during the fall growing season.
"Fundatis herbicide introduces a new solution featuring two active ingredients previously unavailable in Great Britain," said Sebastià Pons, vice president and president of FMC EMEA, in the press release.
This registration marks another regulatory approval for FMC’s Isoflex active ingredient, which has already been registered in several countries including Argentina, Australia, Brazil, China, and India. The company has also submitted a regulatory application for the active ingredient in the European Union.
The herbicide has shown pre-plant, pre-emergence and early post-emergence selectivity in various crops including canola, cereals, oilseed rape and pulses, according to the company statement.
FMC Corporation develops crop protection solutions including biologicals, crop nutrition, and digital agriculture technologies. With five analysts recently revising earnings estimates upward and a strong gross profit margin of 39.5%, the company shows promising fundamentals. For deeper insights into FMC’s financial health and growth prospects, including additional ProTips and comprehensive analysis, visit InvestingPro.
In other recent news, FMC Corporation announced a quarterly dividend of 58 cents per share, maintaining its consistent payment schedule. RBC Capital has raised its price target for FMC to $47 from $40, while keeping a Sector Perform rating, and adjusted its EBITDA estimates for fiscal years 2025 and 2026. Additionally, Wells Fargo upgraded FMC’s stock rating from Equal Weight to Overweight, expressing confidence in the company’s market trends and strategic actions, and raised the price target to $50. FMC’s Tremisia fungicide received regulatory approval in Ukraine, allowing its application on over 10 million hectares of farmland for crops like sunflower and wheat. Furthermore, FMC has entered into a strategic agreement with Corteva Agriscience to expand access to a novel fungicide technology for U.S. corn and soybean growers. This partnership will see both companies marketing products based on the active ingredient fluindapyr. These developments come as FMC continues to focus on enhancing its product offerings and expanding its market presence.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.